CD8A and hepatocellular carcinoma: Robust antitumor immunity in HCC depends strongly on the cDC1 lineage, noted for cross presentation and licensing CD8+ T cells; therefore, preferential restoration or supplementation of cDC1 function is a central avenue to strengthen immunity (117).